台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效

易威

(1799)
  • 股價
    90.9
  • 漲跌
    ▼3.6
  • 漲幅
    -3.81%
  • 成交量
    803
  • 產業
    上櫃 生技醫療類股
  • 65人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
易威 (1799)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/05/09     後一日»

券商獲利排行 - 2024/05/09

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  21.69%1,636.301,636.3101101074.774.7090.9
  21.69%631.80631.83939074.774.7090.9
  17.77%301.80301.82222077.277.2090.9
  17.37%121.10121.199077.477.4090.9
  13.00%99-2.8101.9710376.176.475.490.9
  16.93%65.8065.855077.777.7090.9
  16.50%51.5051.54407878090.9
  16.09%37.8037.833078.378.3090.9
  20.96%31.5031.522075.275.2090.9
  20.86%31.4031.422075.275.2090.9
  13.47%311.729.323176.776.37890.9
  19.92%30.2030.222075.875.8090.9
  18.82%28.8028.822076.576.5090.9
  18.59%28.5028.522076.776.7090.9
  18.28%28.1028.122076.976.9090.9
  4.95%194.514.505476.976.477.590.9
  21.69%16.2016.211074.774.7090.9
  21.52%16.1016.111074.874.8090.9
  20.24%15.3015.311075.675.6090.9
  19.61%14.9014.91107676090.9
  18.05%13.9013.91107777090.9
  1.60%13.513.500111176.976.377.590.9
  17.29%13.4013.411077.577.5090.9
  17.14%13.3013.311077.677.6090.9
  16.69%1301311077.977.9090.9
  16.54%12.9012.91107878090.9
  16.09%12.6012.611078.378.3090.9
  4.32%3.33.3001176.474.77890.9
  1.29%11001177.5777890.9
   00000077.6077.690.9
   0000007777090.9
   00000077.5077.590.9
   00000077.6077.690.9
   00000077.5077.590.9
   0000007777090.9
   0000007777090.9
   00000077.5077.590.9
   0000007707790.9
   0000007707790.9
   0000007777090.9
   00000077.5077.590.9
   00000077.577.5090.9
   00000077.6077.690.9
   00000077.577.5090.9
   00000077.577.5090.9
   00000077.57777.790.9
   0000007777090.9
   0000007807890.9
   00000077.577.577.590.9
   00000077.5077.590.9

券商虧損排行 - 2024/05/09

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -6.32%-624.7-316.9-307.8-191111307677.674.790.9
  -18.05%-2780-278-200207707790.9
  -18.06%-216.6-5.6-211-133167576.574.790.9
  -17.19%-2000-200-1501577.6077.690.9
  -16.54%-167.70-167.7-130137807890.9
  -20.21%-152.80-152.8-1001075.6075.690.9
  -21.69%-113.40-113.4-70774.7074.790.9
  -16.54%-103.20-103.2-8087807890.9
  -18.51%-99.40-99.4-70776.7076.790.9
  -18.13%-83.70-83.7-6067707790.9
  -17.84%-68.80-68.8-50577.1077.190.9
  -17.75%-68.50-68.5-50577.2077.290.9
  -18.05%-55.60-55.6-4047707790.9
  -17.59%-54.40-54.4-40477.3077.390.9
  -16.91%-52.60-52.6-40477.8077.890.9
  -20.10%-45.80-45.8-20375.977.575.690.9
  -19.24%-440-44-30376.2076.290.9
  -18.67%-42.90-42.9-30376.6076.690.9
  -18.05%-41.70-41.7-3037707790.9
  -16.84%-39.30-39.3-30377.8077.890.9
  -16.54%-38.70-38.7-3037807890.9
  -16.54%-38.70-38.7-3037807890.9
  -16.54%-38.70-38.7-3037807890.9
  -18.05%-27.80-27.8-2027707790.9
  -17.75%-27.40-27.4-20277.2077.290.9
  -17.67%-27.30-27.3-20277.3077.390.9
  -17.67%-27.30-27.3-20277.3077.390.9
  -17.59%-27.20-27.2-20277.3077.390.9
  -2.54%-27.214.7-41.9-3111476.475.676.990.9
  -16.92%-26.30-26.3-20277.7077.790.9
  -16.84%-26.20-26.2-20277.8077.890.9
  -16.54%-25.80-25.8-2027807890.9
  -16.54%-25.80-25.8-2027807890.9
  -16.54%-25.80-25.8-2027807890.9
  -16.54%-25.80-25.8-2027807890.9
  -16.09%-25.20-25.2-20278.3078.390.9
  -19.61%-14.90-14.9-1017607690.9
  -18.51%-14.20-14.2-10176.7076.790.9
  -18.21%-140-14-10176.9076.990.9
  -18.21%-140-14-10176.9076.990.9
  -18.05%-13.90-13.9-1017707790.9
  -18.05%-13.90-13.9-1017707790.9
  -18.05%-13.90-13.9-1017707790.9
  -17.75%-13.70-13.7-10177.2077.290.9
  -17.43%-13.50-13.500177.477.677.490.9
  -16.99%-13.20-13.2-10177.7077.790.9
  -16.61%-12.90-12.9-1017807890.9
  -16.54%-12.90-12.9-1017807890.9
  -16.54%-12.90-12.9-1017807890.9
  -16.54%-12.90-12.9-1017807890.9
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音